Next Generation Sequencing Market Gains Momentum as Genomics Becomes Mainstream in Hospitals | Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc.

"Next Generation Sequencing (NGS) Market size reached US$ 13.42 Billion in 2024 and is expected to reach US$ 35.92 Billion by 2033, growing at a CAGR of 11.6% during the forecast period 2025-2033." As per DataM intelligence research report

Market growth opportunities(2025-2031):

The NGS market is poised for remarkable expansion driven by its widening applications in clinical diagnostics, personalized medicine, and oncology. As sequencing becomes faster and more cost-efficient, demand from research institutions and clinical laboratories continues to rise. Innovations like single-cell sequencing and portable sequencing platforms are making NGS more accessible across diverse settings. Additionally, increased funding and collaborations in genomics research are driving market expansion. Integration with AI and cloud-based data platforms further enhances interpretation and accelerates adoption.

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/next-generation-sequencing-ngs-market?sp

Next Generation Sequencing Market: Recent Industry Developments

✅In May 2025 IIT Indore researchers (India) unveil a Quantum AI nanopore nanotechnology approach for unified DNA sequencing, enabling ultra-high-resolution mutation detection via solid state nanopore devices

✅In May 2025 NHS / Genomics England (UK) launches a £650M plan to offer whole-genome sequencing to all newborns in England over the next decade, screening for hundreds of rare diseases

✅In March 2025 Thermo Fisher Scientific expands its Ion Torrent Genexus System by adding new oncology panels for lung and colorectal cancers, accelerating in clinic genomic profiling

Next Generation Sequencing Market: Market Drivers

Key drivers include the falling cost of sequencing, which has made genomic analysis more affordable and scalable. The rise of precision medicine and growing adoption in oncology for tumor profiling are major catalysts. Demand is also growing in reproductive health, rare disease diagnostics, and infectious disease monitoring. Technological improvements in platforms and bioinformatics tools are making NGS faster, more accurate, and user-friendly. Additionally, government and private sector investments in genomics initiatives are fueling further market penetration.

Strategic Players Driving the Next Generation Sequencing Market Forward:

✦ Thermo Fisher Scientific Inc.
✦ Agilent Technologies, Inc.
✦ Bio-Rad Laboratories, Inc.
✦ Qiagen
✦ Eurofins Scientific
✦ Revvity (PerkinElmer Inc.)
✦ Takara Bio Inc.
✦ Illumina Inc.
✦ Alithea Genomics SA
✦ NewBiologix SA

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/next-generation-sequencing-ngs-market?sp

Segment Covered in the Next Generation Sequencing Market:

➥By Product Type: Reagents and Consumables, Instruments, Others
➥By Application: Agriculture and Animal Research, Drug Discovery, Diagnostics, Genetic Screening, Others
➥By Technology: Whole Genome Sequencing, Chip Sequencing, De Novo Sequencing, RNA Sequencing, Methyl Sequencing, Others
➥By End User: Hospitals and Diagnostic Centers, Biotechnology and Pharmaceutical Companies, Academic & Research Institutes, Others

Regional Analysis for Next Generation Sequencing Market:

North America leads the market due to advanced healthcare infrastructure, extensive R&D investment, and early adoption in clinical genomics. Europe is also a strong market with robust regulatory support and rising use in diagnostics. Asia-Pacific is witnessing the fastest growth, driven by increasing healthcare access, rising awareness, and growing investments in genomic medicine across countries like China, India, and Japan.

Why Purchase the Report for Next Generation Sequencing Market?:

➠ Technology & Innovation: Tracks clinical trials and upcoming pharmaceutical advancements to stay ahead in product development.
➠ Market Positioning & Competitive Strategy: Analyzes product performance, market share, and competitor tactics for strategic decision-making.
➠ Real-World Evidence & Physician Insights: Incorporates patient data and physician behavior to align products with actual healthcare needs.
➠ Pricing & Market Access: Reviews reimbursement trends and access models to optimize product pricing and launch strategies.
➠ Regulatory & Industry Shifts: Covers policy changes, health system dynamics, and technology trends impacting market opportunities.
➠ Regional Growth & Expansion: Identifies high-growth markets and investment opportunities for geographic expansion.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=next-generation-sequencing-ngs-market?sp
Conclusion:

Next-Generation Sequencing is transforming modern medicine through its ability to deliver high-throughput, precise genetic insights. The market is set to expand significantly as it moves from research settings into routine clinical use. Players that innovate in bioinformatics, scalability, and accessibility will thrive in this dynamic landscape. With rising global healthcare needs, NGS stands at the forefront of diagnostic and therapeutic advancements.

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.